S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Surmodics (SRDX) News Today

$32.98
+0.19 (+0.58%)
(As of 04:00 PM ET)
SourceHeadline
marketbeat.com logoSurmodics, Inc. (NASDAQ:SRDX) Stock Holdings Lifted by Acadian Asset Management LLC
marketbeat.com - February 22 at 8:27 AM
MarketBeat logoShort Interest in Surmodics, Inc. (NASDAQ:SRDX) Declines By 6.9%
americanbankingnews.com - February 16 at 5:44 AM
MarketBeat logoZacks Research Equities Analysts Cut Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)
americanbankingnews.com - February 16 at 2:02 AM
marketbeat.com logoSurmodics, Inc. (NASDAQ:SRDX) Short Interest Down 6.9% in January
marketbeat.com - February 15 at 4:17 AM
marketbeat.com logoSurmodics, Inc. to Post Q2 2024 Earnings of ($0.34) Per Share, Zacks Research Forecasts (NASDAQ:SRDX)
marketbeat.com - February 14 at 7:58 AM
marketbeat.com logoQ2 2024 EPS Estimates for Surmodics, Inc. (NASDAQ:SRDX) Reduced by Barrington Research
marketbeat.com - February 8 at 7:31 AM
marketbeat.com logoBarrington Research Equities Analysts Lower Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)
marketbeat.com - February 7 at 8:38 AM
ca.finance.yahoo.com logoSYK Jun 2024 290.000 put
ca.finance.yahoo.com - February 6 at 1:03 PM
marketbeat.com logoSurmodics (NASDAQ:SRDX) Issues FY 2024 Earnings Guidance
marketbeat.com - February 4 at 10:53 AM
finance.yahoo.com logoHere's What Analysts Are Forecasting For Surmodics, Inc. (NASDAQ:SRDX) After Its First-Quarter Results
finance.yahoo.com - February 4 at 9:23 AM
finance.yahoo.com logoHere's Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Packet
finance.yahoo.com - February 2 at 5:33 PM
finance.yahoo.com logoSurmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call Transcript
finance.yahoo.com - February 2 at 12:26 PM
finance.yahoo.com logoSurmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View
finance.yahoo.com - February 2 at 12:26 PM
marketwatch.com logoSurmodics Shares Decline 10% on Investors' Lofty Expectations for SurVeil
marketwatch.com - February 1 at 5:53 PM
finance.yahoo.com logoSurmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024
finance.yahoo.com - February 1 at 5:53 PM
msn.com logoSurmodics beats top-line and bottom-line estimates; updates FY24 outlook
msn.com - February 1 at 12:52 PM
finance.yahoo.com logoSurModics (SRDX) Reports Break-Even Earnings for Q1
finance.yahoo.com - February 1 at 12:52 PM
finance.yahoo.com logoSurModics (SRDX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
finance.yahoo.com - February 1 at 12:52 PM
marketbeat.com logoSurmodics (NASDAQ:SRDX) Updates FY 2024 Earnings Guidance
marketbeat.com - February 1 at 9:47 AM
finance.yahoo.com logoSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
finance.yahoo.com - February 1 at 7:52 AM
marketbeat.com logoLos Angeles Capital Management LLC Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX)
marketbeat.com - February 1 at 5:44 AM
benzinga.com logoA Preview Of Surmodics's Earnings
benzinga.com - January 31 at 5:47 PM
finance.yahoo.com logoSurmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
finance.yahoo.com - January 22 at 9:47 AM
finance.yahoo.com logoSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
finance.yahoo.com - January 16 at 9:14 AM
finance.yahoo.com logoReturns Are Gaining Momentum At Surmodics (NASDAQ:SRDX)
finance.yahoo.com - January 10 at 7:03 AM
finance.yahoo.com logoSurmodics, Inc. (SRDX) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - January 8 at 6:36 PM
marketbeat.com logoQ2 2024 Earnings Forecast for Surmodics, Inc. Issued By Zacks Research (NASDAQ:SRDX)
marketbeat.com - December 22 at 6:52 AM
marketbeat.com logoEquities Analysts Offer Predictions for Surmodics, Inc.'s Q2 2025 Earnings (NASDAQ:SRDX)
marketbeat.com - December 15 at 7:10 AM
finance.yahoo.com logoSurModics (SRDX) Soars 6.2%: Is Further Upside Left in the Stock?
finance.yahoo.com - December 14 at 10:30 AM
marketbeat.com logoSurmodics (NASDAQ:SRDX) Lifted to Buy at StockNews.com
marketbeat.com - December 14 at 1:21 AM
marketbeat.com logoSurmodics, Inc. (NASDAQ:SRDX) Short Interest Up 91.9% in November
marketbeat.com - December 13 at 6:37 AM
finance.yahoo.com logoSurmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
finance.yahoo.com - November 16 at 9:58 AM
finance.yahoo.com logoSurmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
finance.yahoo.com - November 16 at 9:58 AM
finance.yahoo.com logoSurmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 91% Above Its Share Price
finance.yahoo.com - November 15 at 8:28 AM
finance.yahoo.com logoSurmodics to Participate in the Piper Sandler Healthcare Conference on November 28
finance.yahoo.com - November 14 at 8:54 PM
finance.yahoo.com logoSurmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - November 11 at 5:31 PM
markets.businessinsider.com logoSurModics Outperforms Projections: Encouraging Financial Results and Promising Product Portfolio Prompt Buy Rating and Raised Price Target
markets.businessinsider.com - November 10 at 11:04 AM
seekingalpha.com logoSurmodics, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - November 9 at 2:18 PM
seekingalpha.com logoSurmodics, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - November 9 at 2:18 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Altimmune (ALT) and SurModics (SRDX)
markets.businessinsider.com - November 9 at 7:47 AM
finance.yahoo.com logoSurModics (SRDX) Reports Q4 Earnings: What Key Metrics Have to Say
finance.yahoo.com - November 8 at 3:56 PM
finance.yahoo.com logoSurmodics Inc (SRDX) Reports Fiscal Year 2023 Earnings Growth and Introduces FY 2024 Guidance
finance.yahoo.com - November 8 at 3:56 PM
finance.yahoo.com logoSurmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
finance.yahoo.com - November 8 at 10:09 AM
finance.yahoo.com logoSurmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
finance.yahoo.com - November 7 at 8:57 AM
finance.yahoo.com logoSurmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
finance.yahoo.com - November 7 at 8:57 AM
finance.yahoo.com logoSurmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
finance.yahoo.com - October 31 at 9:14 AM
finance.yahoo.com logoSurmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
finance.yahoo.com - October 10 at 9:07 AM
finance.yahoo.com logoThe past five years for Surmodics (NASDAQ:SRDX) investors has not been profitable
finance.yahoo.com - October 6 at 2:09 PM
finance.yahoo.com logoSurmodics (SRDX) Hits 52-Week High: What's Driving the Stock?
finance.yahoo.com - September 12 at 1:23 PM
marketbeat.com logoSurmodics, Inc. (NASDAQ:SRDX) Expected to Earn Q1 2024 Earnings of ($0.29) Per Share
marketbeat.com - September 8 at 10:51 AM
Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.



SRDX Media Mentions By Week

SRDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRDX
News Sentiment

1.87

0.45

Average
Medical
News Sentiment

SRDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRDX Articles
This Week

1

2

SRDX Articles
Average Week

Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SRDX) was last updated on 2/26/2024 by MarketBeat.com Staff